ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 915,80
-0,87%
Dow Jones
38 045,92
0,38%
DAX
17 889,74
-0,18%
Brent Oil
83,545
0,01%
Bitcoin
58 644,14
0,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) Actualités

YMAB Y mAbs Therapeutics Inc

16,82
0,33 (2,00%)
Dernière mise à jour : 16:11:34
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Y mAbs Therapeutics Inc YMAB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,33 2,00% 16,82 16:11:34
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
16,49 16,295 16,95 16,49
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202413:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
25/4/202422:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
14/3/202414:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
07/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:49EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:40EDGAR2Form 144 - Report of proposed sale of securities
06/3/202401:05EDGAR2Form 144 - Report of proposed sale of securities
04/3/202413:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
04/3/202412:05EDGAR2Form 8-K - Current report
29/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
29/2/202422:04EDGAR2Form 8-K - Current report
16/2/202413:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
14/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202421:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202412:45EDGAR2Form 8-K - Current report
02/1/202422:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
26/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:40EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
12/12/202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:07EDGAR2Form 144 - Report of proposed sale of securities
13/11/202322:47EDGAR2Form 8-K - Current report
13/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:05GLOBEY-mAbs Reports Third Quarter 2023 Financial Results and..
08/11/202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/10/202312:05GLOBEY-mAbs to Announce Third Quarter 2023 Financial and..
18/10/202322:09EDGAR2Form 8-K - Current report
18/10/202322:05GLOBEY-mAbs Names Michael Rossi as President and Chief Executive..
18/10/202315:00EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
YMAB
Y mAbs Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés